FDA Inspection 1147129 — Henan Lihua Pharmaceutical Co., Ltd.
The FDA completed an inspection of Henan Lihua Pharmaceutical Co., Ltd. on July 13, 2021 in Anyang. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Anyang (China)